24.03.2013 Views

LINEAR ALKYLBENZENE SULFONATE (LAS) - UNEP Chemicals

LINEAR ALKYLBENZENE SULFONATE (LAS) - UNEP Chemicals

LINEAR ALKYLBENZENE SULFONATE (LAS) - UNEP Chemicals

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

OECD SIDS <strong>LINEAR</strong> <strong>ALKYLBENZENE</strong> <strong>SULFONATE</strong> (<strong>LAS</strong>)<br />

Test substance: <strong>LAS</strong> (Na salt), as a slurry containing 64.0% w/v of active ingredient (Lion<br />

Oil and Fat Co., Ltd.); average alkyl chain length (based on <strong>LAS</strong> SIDS<br />

Consortium Survey, 2002) = C11.7-12.3.<br />

Reference: Palmer, A.K. and Lovell, M.R. 1971b. Effect of <strong>LAS</strong> detergent on<br />

pregnancy of the mouse. Report No. 4330/71/486.<br />

Reliability: 2 Valid with restrictions<br />

(e)<br />

Species/strain: Mouse/CD-1<br />

Sex: Female [X]; Male [ ]; Male/Female [ ]; No data [ ]<br />

Administration: gavage<br />

Duration of the test: sacrifice at day 17 of pregnancy<br />

Exposure period: days 6 - 15 of pregnancy<br />

Frequency of treatment:daily<br />

Doses: 0.2, 2, 300, 600 mg/kg bw d<br />

Control group: Yes [X]; No [ ]; No data [ ];<br />

Concurrent no treatment [X]; Concurrent vehicle [ ]; Historical [ ]<br />

NOAEL Maternal<br />

Toxicity: 2 mg/kg bw d<br />

NOAEL teratogenicity: 300 mg/kg bw d<br />

Results: Maternal toxicity:<br />

Among parent animals treatment at 300 and 600 mg/kg bw d was associated<br />

with increased mortality (35% and 90% respectively). At 300 mg/kg bw d<br />

weight gain was retarded only during the first four days. No assessment<br />

could be made at 600 mg/kg bw d, due to the high mortality rate. Necropsy<br />

revealed a ubiquitous occurrence of tympanites, sometimes associated with<br />

gastritis. Pregnancy rate was essentially comparable for all groups.<br />

Teratogenicity:<br />

At doses with no maternal toxicity, no differences were observed among the<br />

dose group and the control group with respect to number of litters, viable<br />

young, litter weight, foetal weight, embryonic deaths, implantations and post<br />

implantation embryonic loss. At these doses the incidences of major<br />

malformations and minor abnormalities were not affected. At doses with<br />

maternal toxicity there was an increased foetal loss and reduced litter size<br />

due almost entirely to total litter loss, which was considered to be a<br />

secondary effect due to the maternal toxicity. The incidences of major<br />

malformations was not affected; minor skeletal or visceral anomalies were<br />

increased at 300 mg/kg.<br />

Method: Twenty female mice were administered 0.2, 2.0, 300, or 600 mg/kg bw of<br />

<strong>LAS</strong> by gavage at days 6-15 of gestation. All animals were sacrificed at day<br />

17 of pregnancy.<br />

GLP: Yes [ ] No [X] ? [ ]<br />

Test substance: <strong>LAS</strong><br />

Remarks: The maternal NOAEL of 2 mg/kg bw d is considered very conservative<br />

because the range (2-300 mg/kg bw d) was too wide.<br />

Reference: Palmer, A.K., Readshaw, M.A. and Neuff, A.M. 1975a. Assessment of<br />

the teratogenic potential of surfactants (Part I) – <strong>LAS</strong>, AS and CLD.<br />

Toxicology 3:91-106.<br />

Reliability: 2 Valid with restrictions<br />

(f)<br />

Species/strain: New Zealand white rabbit<br />

Sex: Female [X]; Male [ ]; Male/Female [ ]; No data [ ]<br />

Administration: Gavage<br />

Exposure period: day 6 to 18 of pregnancy<br />

Frequency of treatment: Daily<br />

<strong>UNEP</strong> PUBLICATIONS 293

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!